Form 4: Acadia Healthcare Director Michael Fucci Receives Significant Equity Grant

Acadia Healthcare Company, Inc. Director Michael Fucci was granted 7,032 shares of common stock, which will vest over three years, increasing his total beneficial ownership to 21,821 shares.

Summary

• Michael Fucci, a Director of Acadia Healthcare Company, Inc. (ACHC), acquired 7,032 shares of common stock.
• The transaction occurred on May 29, 2025, at a price of $0 per share, indicating a grant rather than a direct purchase.
• These acquired shares are subject to a vesting schedule, with equal yearly installments over a 3-year period beginning May 29, 2026.
• Following this acquisition, Michael Fucci's total beneficial ownership in Acadia Healthcare Company, Inc. stands at 21,821 shares of common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, particularly through a compensation grant with a vesting schedule, generally indicates alignment of interests and confidence in the company's future, which is a positive signal for investors.

Positives

• Director Michael Fucci's increased equity stake through the grant aligns his financial interests more closely with those of the company's shareholders.
• The grant of shares at a $0 price is typical for equity compensation, serving as an incentive for long-term performance and commitment from the director.

Future Outlook

The document indicates a future vesting schedule for the granted shares, with the first installment beginning on May 29, 2026, and continuing over a three-year period.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction and does not provide broader industry context or trends within the healthcare sector.

Related Party Transactions

• The acquisition of 7,032 shares of common stock by Director Michael Fucci at a $0 price constitutes a related party transaction, specifically an equity grant as part of compensation.

Stakeholder Impact

• Shareholders: The increased equity ownership by a director enhances the alignment of management's interests with shareholder value, potentially leading to more shareholder-friendly decisions.
• Employees/Management: This transaction reflects the company's ongoing practice of using equity compensation to incentivize and retain key personnel, including directors.

Next Steps

• Future vesting installments of the granted shares will occur annually, starting on May 29, 2026, for a period of three years.

Key Dates

Recommendation

Keywords

Acadia Healthcare, ACHC, Michael Fucci, Director, Stock Grant, Equity Compensation, Insider Ownership, Form 4, SEC Filing